The Suspected CANcer (SCAN) pathway: protocol for evaluating a new standard of care for patients with non-specific symptoms of cancer

被引:33
|
作者
Nicholson, Brian D. [1 ]
Oke, Jason [1 ]
Smith, Claire Friedemann [1 ]
Phillips, Julie-Ann [2 ]
Lee, Jennifer [2 ]
Abel, Lucy [1 ]
Kelly, Sadie [1 ]
Gould, Isabella [1 ]
Mackay, Toni [2 ]
Kaveney, Zoe [3 ]
Anthony, Suzie [2 ]
Hayles, Shelley [3 ]
Lasserson, Daniel [2 ,4 ]
Gleeson, Fergus [2 ]
机构
[1] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England
[2] Oxford Univ Hosp NHS Fdn Trust, Oxford, England
[3] Oxfordshire Clin Commissioning Grp, Delivery & Local Directorate, Oxford, England
[4] Univ Oxford, Nuffield Dept Med, Oxford, England
来源
BMJ OPEN | 2018年 / 8卷 / 01期
关键词
INCIDENTAL FINDINGS; GENERAL-PRACTICE; LUNG-CANCER; DIAGNOSIS; SURVIVAL; CT; CALCIFICATION; DISEASE; EUROPE; ACCESS;
D O I
10.1136/bmjopen-2017-018168
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Cancer survival in England lags behind most European countries, due partly to lower rates of early stage diagnosis. We report the protocol for the evaluation of a multidisciplinary diagnostic centre-based pathway for the investigation of 'low-risk but not no-risk' cancer symptoms called the Suspected CANcer (SCAN) pathway. SCAN is a new standard of care being implemented in Oxfordshire; one of a number of pathways implemented during the second wave of the Accelerate, Coordinate, Evaluate (ACE) programme, an initiative which aims to improve England's cancer survival rates through establishing effective routes to early diagnosis. Methods and analysis To evaluate SCAN, we are collating a prospective database of patients referred onto the pathway by their general practitioner (GP). Patients aged over 40 years, with non-specific symptoms such as weight loss or fatigue, who do not meet urgent cancer referral criteria or for whom symptom causation remains unclear after investigation via other existing pathways, can be referred to SCAN. SCAN provides rapid CT scanning, laboratory testing and clinic review within 2 weeks. We will follow all patients in the primary and secondary care record for at least 2 years. The data will be used to understand the diagnostic yield of the SCAN pathway in the short term (28 days) and the long term (2 years). Routinely collected primary and secondary care data from patients not referred to SCAN but with similar symptoms will also be used to evaluate SCAN. We will map the routes to diagnosis for patients referred to SCAN to assess cost-effectiveness. Acceptability will be evaluated using patient and GP surveys. Ethics and dissemination The Oxford Joint Research Office Study Classification Group has judged this to be a service evaluation and so outside of research governance. The results of this project will be disseminated by peer reviewed publication and presentation at conferences.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] The pathway and characteristics of patients with non-specific symptoms of cancer: a systematic review
    Jensen, Ellen
    Kristensen, Jette Kolding
    Bjerglund, Rikke Tveden
    Johnsen, Soren Paaske
    Thomsen, Janus Laust
    [J]. BMC CANCER, 2022, 22 (01)
  • [2] The pathway and characteristics of patients with non-specific symptoms of cancer: a systematic review
    Ellen Jensen
    Jette Kolding Kristensen
    Rikke Tveden Bjerglund
    Søren Paaske Johnsen
    Janus Laust Thomsen
    [J]. BMC Cancer, 22
  • [3] Incidental findings in a referral pathway for non-specific cancer symptoms
    Murchison, Andrew G.
    Moreland, Julie-Ann
    Gleeson, Fergus
    [J]. CLINICAL IMAGING, 2021, 77 : 9 - 12
  • [4] Non-specific symptoms and signs of cancer: different organisations of a cancer patient pathway in Denmark
    Damhus, Christina Sadolin
    Siersma, Volkert
    Dalton, Susanne Oksbjerg
    Brodersen, John
    [J]. SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE, 2021, 39 (01) : 23 - 30
  • [6] Diagnostic performance of blood tests in cancer diagnostics in patients with non-specific cancer symptoms
    Naeser, Esben
    Fredberg, Ulrich
    Moller, Henrik
    Vedsted, Peter
    [J]. EUROPEAN JOURNAL OF CANCER CARE, 2015, 24 : 49 - 50
  • [7] The Danish cancer pathway for patients with serious non-specific symptoms and signs of cancer–a cross-sectional study of patient characteristics and cancer probability
    Mads Lind Ingeman
    Morten Bondo Christensen
    Flemming Bro
    Søren T. Knudsen
    Peter Vedsted
    [J]. BMC Cancer, 15
  • [8] Building the case for the use of gut feelings in cancer referrals: perspectives of patients referred to a non-specific symptoms pathway
    Smith, Claire Friedemann
    Kristensen, Benedikte Moller
    Andersen, Rikke Sand
    Ziebland, Sue
    Nicholson, Brian D.
    [J]. BRITISH JOURNAL OF GENERAL PRACTICE, 2022, 72 (714): : E43 - E50
  • [9] Luckily-I am not the worrying kind: Experiences of patients in the Danish cancer patient pathway for non-specific symptoms and signs of cancer
    Damhus, Christina Sadolin
    Brodersen, John Brandt
    Risor, Mette Bech
    [J]. HEALTH, 2023, 27 (06): : 1059 - 1075
  • [10] Characteristics and outcome in patients with non-specific symptoms and signs of cancer referred to a fast track cancer patient pathway; a retrospective cohort study
    Sara Falk Jørgensen
    Pernille Ravn
    Søren Thorsen
    Signe Westring Worm
    [J]. BMC Cancer, 17